lung cancer

Business Jonathan Saltzman — Boston Globe

STAT Plus: Bayer to invest in Boston lab focused on chronic lung conditions

Business Adam Feuerstein

STAT Plus: Roche reshuffles lung cancer immunotherapy market with positive clinical trial results

Pharma Adam Feuerstein

STAT Plus: AstraZeneca immunotherapy study shows benefit for niche group of lung cancer patients

First Opinion Linnea Olson and Michael Misialek

A cancer patient and pathologist — brought together by Twitter — strike up an unlikely connection

In the Lab Sharon Begley

First CRISPR trial in humans is reported to start next month

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: UK refuses to cover Bristol lung cancer drug

Quick Take Eric Boodman

To quit smoking, go cold turkey

Quick Take Megan Thielking

High rates of certain cancers plague Asian-Americans